AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8335014 — intervention group
Group type: COMPARATOR
Intervention: DTPw vaccine
Number of subjects: 218
Study 3720707 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended phenytoin sodium capsules (Dilantin Kapseals) - 3 capsules of 100 mg each (276 mg free acid)
Number of subjects: 7
Study 3720707 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin oral suspension (Dilantin oral suspension) - 11 ml (275 mg)
Number of subjects: 7
Study 28735720 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic training program (n=17)
Number of subjects: 32
Study 28735720 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 32
Study 27340358 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral E. coli Nissle therapy (2 capsules daily for one month)
Number of subjects: 57
Study 27340358 — intervention group
Group type: COMPARATOR
Intervention: Control group (vegetarian diet and topical therapy only)
Number of subjects: 57
Study 25907781 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-intervention TEG measurements
Number of subjects: 184
Study 23554283 — intervention group
Group type: COMPARATOR
Intervention: Creatine supplementation
Number of subjects: 0
Study 23554283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20447097 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical implantable collamer lens (ICL)
Number of subjects: 126
Study 18199999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl-eicosapentaenoic acid (E-EPA)
Number of subjects: 24
Study 16185307 — intervention group
Group type: EXPERIMENTAL
Intervention: VSL# 3
Number of subjects: 48
Study 16185307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 12923020 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic shock at 200 J
Number of subjects: 227
Study 12923020 — intervention group
Group type: COMPARATOR
Intervention: Biphasic shock at 120 J
Number of subjects: 227
Study 12923020 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic shock at 360 J
Number of subjects: 227
Study 12923020 — intervention group
Group type: COMPARATOR
Intervention: Biphasic shock at 200 J
Number of subjects: 227
Study 12923020 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic shocks
Number of subjects: 227
Study 12923020 — intervention group
Group type: COMPARATOR
Intervention: Biphasic shocks
Number of subjects: 227
Study 10784550 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9002328 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet A (cereals, vegetable oil, and animal milk or yoghurt)
Number of subjects: 460
Study 9002328 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet B (lactose free, energy from cereals partially replaced by simple sugars)
Number of subjects: 460
Study 9002328 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment algorithm (including locally available foods, vitamin and mineral supplementation, selective use of antibiotics)
Number of subjects: 460
Study 1463114 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of EBSLN using a nerve stimulator during dissection by the first author.
Number of subjects: 76
Study 1463114 — intervention group
Group type: COMPARATOR
Intervention: No nerve search during dissection executed by a resident.
Number of subjects: 76
Study 1463114 — intervention group
Group type: COMPARATOR
Intervention: No nerve search during dissection undertaken by the first author.
Number of subjects: 76
Study 6475754 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) group
Number of subjects: 12866
Study 6475754 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 12866
Study 30735266 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised neonatal parent support programme (four individual nurse-parent dialogues during hospitalisation)
Number of subjects: 231
Study 30735266 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised neonatal parent support programme
Number of subjects: 231
Study 30735266 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 231
Study 29510223 — intervention group
Group type: EXPERIMENTAL
Intervention: TSP + ALC
Number of subjects: 225
Study 29510223 — intervention group
Group type: COMPARATOR
Intervention: TSP
Number of subjects: 225
Study 27002354 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural intervention targeting adolescent sexual risk behaviours
Number of subjects: 0
Study 25113081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol and norepinephrine levels in patients with stroke who developed infections on day 3
Number of subjects: 39
Study 25113081 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma IL-6 and IL-10 levels in patients with stroke who developed infections on day 3
Number of subjects: 39
Study 25113081 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality in patients with infection
Number of subjects: 39
Study 25113081 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery of immune system post-infection
Number of subjects: 39
Study 22190134 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise during weight regain
Number of subjects: 40
Study 22190134 — intervention group
Group type: COMPARATOR
Intervention: No exercise during weight regain
Number of subjects: 40
Study 20717077 — intervention group
Group type: EXPERIMENTAL
Intervention: MLC2.5
Number of subjects: 43
Study 20717077 — intervention group
Group type: COMPARATOR
Intervention: MLC5
Number of subjects: 43
Study 17667684 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue engineering technique with bone marrow stem cells in a resorbable matrix
Number of subjects: 0
Study 17667684 — intervention group
Group type: COMPARATOR
Intervention: Traditional iliac crest bone graft
Number of subjects: 0
Study 17667684 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive iliac crest bone graft
Number of subjects: 0
Study 15842914 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-instrumented group
Number of subjects: 81
Study 15842914 — intervention group
Group type: COMPARATOR
Intervention: Instrumented group
Number of subjects: 81
Study 12173728 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose plus glibenclamide
Number of subjects: 84
Study 12173728 — intervention group
Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 84
Study 12173728 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 84
Study 12173728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 9449728 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited-ventilation group (peak inspiratory pressure maintained at 30 cm of water or less, tidal volume at 8 ml per kilogram or less)
Number of subjects: 120
Study 9449728 — intervention group
Group type: COMPARATOR
Intervention: Control group (peak inspiratory pressure allowed to rise as high as 50 cm of water, tidal volume at 10 to 15 ml per kilogram)
Number of subjects: 120
Study 9449728 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited-ventilation group
Number of subjects: 120
Study 7657765 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal HOS scores (mean HOS score 70.0%)
Number of subjects: 27
Study 7657765 — intervention group
Group type: COMPARATOR
Intervention: Subnormal HOS scores (mean HOS score 36.7%)
Number of subjects: 27
Study 2627387 — intervention group
Group type: EXPERIMENTAL
Intervention: IV labetalol at doses of 0.25, 0.5, 0.75, or 1 mg/kg
Number of subjects: 60
Study 2627387 — intervention group
Group type: COMPARATOR
Intervention: IV saline (placebo)
Number of subjects: 60
Study 4706912 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective vagotomy
Number of subjects: 40
Study 4706912 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy
Number of subjects: 40
Study 4706912 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective vagotomy plus pyloroplasty
Number of subjects: 40
Study 4706912 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy plus pyloroplasty
Number of subjects: 40
Study 31901229 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-articular injection (PAI)
Number of subjects: 60
Study 31901229 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular injection (IAI)
Number of subjects: 60
Study 31254462 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged capecitabine chemotherapy (1000 mg/m² per day for 2 weeks, repeated every 3 weeks for 8 cycles at most)
Number of subjects: 212
Study 31254462 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged capecitabine chemotherapy
Number of subjects: 212
Study 31254462 — intervention group
Group type: COMPARATOR
Intervention: Control group (no prolonged chemotherapy)
Number of subjects: 212
Study 28323965 — intervention group
Group type: EXPERIMENTAL
Intervention: C-terminal peptide-modified hGH (MOD-4023) at doses of 0.25, 0.48, or 0.66 mg/kg/wk
Number of subjects: 53
Study 28323965 — intervention group
Group type: COMPARATOR
Intervention: Daily recombinant human GH (r-hGH) at a dose of 0.24 mg/kg/wk
Number of subjects: 53
Study 25293405 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of psychological distress
Number of subjects: 19
Study 25293405 — intervention group
Group type: EXPERIMENTAL
Intervention: Labile moods
Number of subjects: 19
Study 25293405 — intervention group
Group type: EXPERIMENTAL
Intervention: Less ability to regulate emotional states
Number of subjects: 19
Study 25293405 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological distress
Number of subjects: 19
Study 23142669 — intervention group
Group type: EXPERIMENTAL
Intervention: LIBER8 intervention (Linking Individuals Being Emotionally Real)
Number of subjects: 0
Study 23142669 — intervention group
Group type: COMPARATOR
Intervention: 2BFit (weight management control condition)
Number of subjects: 0
Study 21044831 — intervention group
Group type: EXPERIMENTAL
Intervention: SOD/gliadin supplement (500 mg/day for 12 weeks)
Number of subjects: 38
Study 21044831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 19785256 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic group (received cues, strategy training, and feedback during an object search task)
Number of subjects: 40
Study 19785256 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard pretests and posttests of unilateral neglect)
Number of subjects: 40
Study 16788927 — intervention group
Group type: EXPERIMENTAL
Intervention: Porfimer sodium photodynamic therapy (ps‐PDT)
Number of subjects: 0
Study 16788927 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant thermal ablation
Number of subjects: 0
Study 16788927 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor therapy
Number of subjects: 0
Study 15294219 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg)
Number of subjects: 0
Study 15294219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12011968 — intervention group
Group type: EXPERIMENTAL
Intervention: HR (Paroven, Venoruton; 0‐(beta‐hydroxyethyl)‐rutosides)
Number of subjects: 40
Study 12011968 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 9715584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-EE relatives
Number of subjects: 48
Study 9715584 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients from high-EE families
Number of subjects: 48
Study 9715584 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients from low-EE families
Number of subjects: 48
Study 9715584 — intervention group
Group type: EXPERIMENTAL
Intervention: High-EE families
Number of subjects: 48
Study 7641249 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 19
Study 7641249 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 2666451 — intervention group
Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 0
Study 2666451 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 13342 — intervention group
Group type: EXPERIMENTAL
Intervention: Group systematic desensitization (n = 8)
Number of subjects: 19
Study 13342 — intervention group
Group type: EXPERIMENTAL
Intervention: Group flooding (n = 7)
Number of subjects: 19
Study 13342 — intervention group
Group type: COMPARATOR
Intervention: Group discussion‐placebo control treatment (n = 4)
Number of subjects: 19
Study 31899509 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial random noise stimulation (30 minutes, 2 mA direct current offset, random noise range of 2 mA)
Number of subjects: 66
Study 31899509 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial random noise stimulation
Number of subjects: 66
Study 31899509 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial random noise stimulation
Number of subjects: 66
Study 28233459 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily plus vitamin D 60,000 units once weekly
Number of subjects: 28
Study 28233459 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 40 mg daily
Number of subjects: 28
Study 28233459 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 60,000 units once weekly
Number of subjects: 28
Study 25500317 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (155-195 U)
Number of subjects: 688
Study 23471421 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralized depression care (patient preference for problem-solving treatment via telephone or Internet, pharmacotherapy, both, or neither) for 6 months (active treatment group; n = 73)
Number of subjects: 150
Study 23471421 — intervention group
Group type: COMPARATOR
Intervention: Usual care (locally determined depression care after physician notification about the patient's depressive symptoms; usual care group; n = 77)
Number of subjects: 150
Study 21214584 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffy coat (BC) PLTs
Number of subjects: 14
Study 21214584 — intervention group
Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP) PLTs
Number of subjects: 14
Study 19272066 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower septal pacing
Number of subjects: 36
Study 19272066 — intervention group
Group type: COMPARATOR
Intervention: RV apical pacing
Number of subjects: 36
Study 17912670 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerasorb with PRP
Number of subjects: 26
Study 17912670 — intervention group
Group type: COMPARATOR
Intervention: Cancellous bone from the iliac crest
Number of subjects: 26
Study 15566540 — intervention group
Group type: EXPERIMENTAL
Intervention: Training as a complex intervention
Number of subjects: 0
Study 15566540 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative and qualitative approaches
Number of subjects: 0
Study 11507918 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene program (instruction on brushing, flossing, and professional tooth cleaning)
Number of subjects: 55
Study 11507918 — intervention group
Group type: COMPARATOR
Intervention: Negative control (10 students with no oral hygiene training)
Number of subjects: 55
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg D‐alpha‐tocopheryl acetate plus 250 mg slow‐release ascorbic acid twice a day (n = 20)
Number of subjects: 142
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg D‐alpha‐tocopheryl acetate twice a day (n = 20)
Number of subjects: 142
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg ascorbic acid twice a day (n = 21)
Number of subjects: 142
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg slow‐release ascorbic acid twice a day (n = 21)
Number of subjects: 142
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg coenzyme Q10 in oil three times a day (n = 20)
Number of subjects: 142
Study 9022536 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg coenzyme Q10 as granulate three times a day (n = 20)
Number of subjects: 142
Study 9022536 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice a day (n = 20)
Number of subjects: 142
Study 7932284 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 x 50 micrograms GHRH
Number of subjects: 10
Study 7932284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31828820 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP laser ablation
Number of subjects: 24
Study 31828820 — intervention group
Group type: COMPARATOR
Intervention: CO2 laser cordectomy
Number of subjects: 24
Study 31158801 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory control training (5-week computerized and adaptive training)
Number of subjects: 60
Study 31158801 — intervention group
Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 60
Study 28957341 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy course
Number of subjects: 101
Study 28957341 — intervention group
Group type: COMPARATOR
Intervention: 14-day quadruple regimen
Number of subjects: 101
Study 25689986 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Acupuncture (RA)
Number of subjects: 25
Study 25689986 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 25
Study 23907442 — intervention group
Group type: EXPERIMENTAL
Intervention: Fotonovela (Entertainment-Education)
Number of subjects: 142
Study 23907442 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 142
Study 21827533 — intervention group
Group type: EXPERIMENTAL
Intervention: Videogame training for 2.5 hours across 5 days
Number of subjects: 0
Study 16096787 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin 1-7 (A(1-7)) administered at a dose of 100 microg/kg per day for at least 10 days after chemotherapy.
Number of subjects: 20
Study 16096787 — intervention group
Group type: COMPARATOR
Intervention: Filgrastim (control group) administered over three cycles of chemotherapy.
Number of subjects: 20
Study 12885265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.1% applied to face (standard application)
Number of subjects: 52
Study 12885265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.1% applied to 15% body surface area (exaggerated application)
Number of subjects: 52
Study 12885265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.1% applied to face (standard application) in photodamaged skin
Number of subjects: 52
Study 12885265 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene cream 0.1% applied to 15% body surface area (exaggerated application) in photodamaged skin
Number of subjects: 52
Study 11115436 — intervention group
Group type: EXPERIMENTAL
Intervention: IV methylprednisolone (125 mg)
Number of subjects: 25
Study 11115436 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 25
Study 11115436 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (5 x 500 microg inhaled)
Number of subjects: 25
Study 11115436 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (first day)
Number of subjects: 25
Study 11115436 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (first day)
Number of subjects: 25
Study 9213864 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (SS) perfusion at 250 mcg/h for 48 hours
Number of subjects: 47
Study 9213864 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) - physiologic saline 0.9%
Number of subjects: 47
Study 8232171 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV counseling interventions
Number of subjects: 0
Study 8232171 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention
Number of subjects: 0
Study 4024910 — intervention group
Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (5 micrograms/h, one and two patches)
Number of subjects: 16
Study 4024910 — intervention group
Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (two patches)
Number of subjects: 16
Study 4024910 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (100 mg)
Number of subjects: 16
Study 31330901 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of breastfeeding
Number of subjects: 212
Study 31330901 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of fish, fruits, and vegetables
Number of subjects: 212
Study 29562883 — intervention group
Group type: COMPARATOR
Intervention: Multi-component, community-sport based program targeting prevention, promotion and early intervention for mental health.
Number of subjects: 0
Study 29562883 — intervention group
Group type: COMPARATOR
Intervention: Messaging campaign aimed at adolescents to enhance mental health literacy.
Number of subjects: 0
Study 27581812 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck suction at -60 Torr during moderate-intensity exercise
Number of subjects: 15
Study 27581812 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck suction at -60 Torr during low-intensity exercise
Number of subjects: 15
Study 27581812 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 15
Study 24810956 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS (transcranial random noise stimulation) applied to unilateral M1 (primary motor cortex)
Number of subjects: 0
Study 24810956 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral tDCS (transcranial direct current stimulation) applied to unilateral M1
Number of subjects: 0
Study 24810956 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral tDCS applied to M1
Number of subjects: 0
Study 24810956 — intervention group
Group type: COMPARATOR
Intervention: Control stimulation of the right temporal lobe
Number of subjects: 0
Study 23278574 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 42
Study 23278574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 20016142 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 22
Study 20016142 — intervention group
Group type: COMPARATOR
Intervention: Paricalcitol
Number of subjects: 22
Study 20016142 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Ca absorption
Number of subjects: 22
Study 20016142 — intervention group
Group type: COMPARATOR
Intervention: Serum PTH, Ca, phosphorus (P), or Ca x P
Number of subjects: 22
Study 17296655 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-times-daily (TID) heparin dosing
Number of subjects: 7978
Study 17296655 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily (BID) heparin dosing
Number of subjects: 7978